Abstracts - faqs.org

Abstracts

Business

Search abstracts:
Abstracts » Business

Sandoz slims down

Article Abstract:

Sandoz is carrying out disposals prior to a merger with Ciba. The company has sold Master Builders Technologies to SKW Trostberg for 1.3 billion Swiss francs. The price is higher than forecast and the sale was carried out more rapidly than expected. Further disposals are likely by both Sandoz and Ciba. Ciba is likely to sell Mettler-Toledo, involved in weighing machines. Ciba's specialty chemicals division is also likely to be sold following the merger.

Publisher: FT Business
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1996
Chemicals & Allied Products, Chemical Manufacturing, CHEMICALS AND ALLIED PRODUCTS, Chemicals, Chemical industry, Sandoz AG, Ciba-Geigy Corp.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Meconic bid creates shareholder buzz

Article Abstract:

The background to and impact of a Johnson Matthey bid for Meconic are examined in detail. The bid appears likely to be successful, and will allow investors to take profits.

Publisher: FT Business
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2001
Johnson Matthey

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Meconic

Article Abstract:

Meconic has high borrowings, but a niche position in the British market for opiates.

Publisher: FT Business
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2001
Management

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Pharmaceutical industry, Mergers, acquisitions and divestments, Drugs, Meconic
Similar abstracts:
  • Abstracts: Plan of action. Don't imitate Conrad's hero. A gift of an investment
  • Abstracts: Glickenhaus & Co. Electronic brokers. The Advest Group, Inc
  • Abstracts: Power of speech. More gloom ahead for Marconi shareholders. Patientline
  • Abstracts: Pensions innovation deserves applause. Guaranteed, but not for long. Long run performance
  • Abstracts: Beware charges swimming offshore. Performance
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.